LU70985A1 - - Google Patents

Info

Publication number
LU70985A1
LU70985A1 LU70985A LU70985A LU70985A1 LU 70985 A1 LU70985 A1 LU 70985A1 LU 70985 A LU70985 A LU 70985A LU 70985 A LU70985 A LU 70985A LU 70985 A1 LU70985 A1 LU 70985A1
Authority
LU
Luxembourg
Application number
LU70985A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU70985A1 publication Critical patent/LU70985A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
LU70985A 1973-09-26 1974-09-24 LU70985A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732349024 DE2349024A1 (de) 1973-09-26 1973-09-26 6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione

Publications (1)

Publication Number Publication Date
LU70985A1 true LU70985A1 (en:Method) 1975-03-06

Family

ID=5894080

Family Applications (1)

Application Number Title Priority Date Filing Date
LU70985A LU70985A1 (en:Method) 1973-09-26 1974-09-24

Country Status (16)

Country Link
US (1) US3965128A (en:Method)
JP (1) JPS5059362A (en:Method)
AR (1) AR202946A1 (en:Method)
AU (1) AU7374074A (en:Method)
BE (1) BE820381A (en:Method)
DD (1) DD114599A5 (en:Method)
DE (1) DE2349024A1 (en:Method)
DK (1) DK507974A (en:Method)
FI (1) FI280574A7 (en:Method)
FR (1) FR2244492A1 (en:Method)
IL (1) IL45629A0 (en:Method)
LU (1) LU70985A1 (en:Method)
NL (1) NL7412747A (en:Method)
NO (1) NO743449L (en:Method)
SE (1) SE7412058L (en:Method)
ZA (1) ZA746131B (en:Method)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1399199A (en) * 1997-11-14 1999-06-07 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US6022890A (en) * 1997-11-14 2000-02-08 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
CA2584485C (en) * 2004-10-20 2013-12-31 Resverlogix Corp. Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
JP5368792B2 (ja) * 2005-07-29 2013-12-18 レスバーロジックス コーポレイション 複合疾患の予防および処置のための薬学的組成物および挿入可能な医療用デバイスによるその送達
DK2118074T3 (en) * 2007-02-01 2014-03-10 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular diseases
KR101629356B1 (ko) 2008-06-26 2016-06-13 리스버로직스 코퍼레이션 퀴나졸리논 유도체의 제조방법
NZ594332A (en) 2009-01-08 2013-09-27 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular disease
KR101709492B1 (ko) 2009-03-18 2017-02-23 리스버로직스 코퍼레이션 신규한 소염제
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
RU2640115C2 (ru) 2011-11-01 2017-12-26 Ресверлоджикс Корп. Фармацевтические композиции замещенных хиназолинонов
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
US9271978B2 (en) 2012-12-21 2016-03-01 Zenith Epigenetics Corp. Heterocyclic compounds as bromodomain inhibitors
US10111885B2 (en) 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Also Published As

Publication number Publication date
DD114599A5 (en:Method) 1975-08-12
IL45629A0 (en) 1974-11-29
NL7412747A (nl) 1975-04-01
ZA746131B (en) 1975-09-24
FI280574A7 (en:Method) 1975-03-27
BE820381A (fr) 1975-03-26
FR2244492A1 (en:Method) 1975-04-18
NO743449L (en:Method) 1975-04-28
AR202946A1 (es) 1975-07-31
DK507974A (en:Method) 1975-06-09
DE2349024A1 (de) 1975-04-10
US3965128A (en) 1976-06-22
JPS5059362A (en:Method) 1975-05-22
SE7412058L (en:Method) 1975-03-27
AU7374074A (en) 1976-04-01

Similar Documents

Publication Publication Date Title
AR201758A1 (en:Method)
AU465372B2 (en:Method)
AR201235Q (en:Method)
AR201231Q (en:Method)
AU474593B2 (en:Method)
AU474838B2 (en:Method)
AU465453B2 (en:Method)
AU471343B2 (en:Method)
AU465434B2 (en:Method)
DK507974A (en:Method)
AR201229Q (en:Method)
AU472848B2 (en:Method)
AU466283B2 (en:Method)
AU477823B2 (en:Method)
AR195948A1 (en:Method)
AR200885A1 (en:Method)
AR201432A1 (en:Method)
AU471461B2 (en:Method)
AR196382A1 (en:Method)
AR210729A1 (en:Method)
AU447540B2 (en:Method)
AU1891376A (en:Method)
AR196123Q (en:Method)
AU5288973A (en:Method)
AR196212Q (en:Method)